UK transplantation trials network: four IMPACT trials launching in 2018
What can clonal evolution in chronic lymphocytic leukemia (CLL) tell us about outcomes?
Inspired by the EBMT Nurses Group: the potential for a BMT Nurses Group in India
Evolving CLL treatments: creating choices and igniting discussions
Deborah Henderson et al.
HMPRO: collecting specific QoL and symptom data for hematological malignancies